Montréal-Based VC Fund Invests in UK Startup Ixchelsis
TVM Life Science Ventures VII has made an investment in Ixchelsis Ltd. No financial terms were disclosed. Based in Sandwich, Kent, United Kingdom, Ixchelsis will focus on developing IX-01 to treat male sexual health disorders. Managed by TVM Capital Life Science, an international venture capital firm, TVM Life Science Ventures VII is a venture capital fund based in Montréal. Update: Earlier in 2013, the $150 million fund made its first investment in Montréal's Kaneq Bioscience Ltd.
6 August 2013•5 mins read
